David Shaw’s Tango Therapeutics TNGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.51M Buy
+60,382
New +$1.57M ﹤0.01% 3460
2026
Q1
– Sell
-1,025,553
Closed -$9.09M – 5066
2025
Q4
$9.09M Buy
1,025,553
+595,174
+138% +$5.13M 0.01% 1849
2025
Q3
$3.62M Buy
+430,379
New +$2.91M ﹤0.01% 2500
2025
Q2
– Sell
-68,269
Closed -$93.5K – 4716
2025
Q1
$93.5K Sell
68,269
-46,558
-41% -$114K ﹤0.01% 4027
2024
Q4
$355K Buy
+114,827
New +$533K ﹤0.01% 3807
2024
Q1
– Sell
-15,413
Closed -$153K – 4745
2023
Q4
$153K Buy
+15,413
New +$134K ﹤0.01% 3922
2023
Q1
– Sell
-30,404
Closed -$220K – 4865
2022
Q4
$220K Sell
30,404
-74,487
-71% -$524K ﹤0.01% 4209
2022
Q3
$380K Sell
104,891
-72,525
-41% -$310K ﹤0.01% 4203
2022
Q2
$804K Buy
+177,416
New +$1.07M ﹤0.01% 3774

Other funds holding TNGX

David Shaw's TNGX Position: Q3 2026 in Review

David Shaw opened a new position in Tango Therapeutics (TNGX) in Q3 2026: 60,382 shares worth $1.51M. The stake represents ﹤0.01% of the portfolio and ranks #3460 among its holdings. This is a return to the name: David Shaw previously reported a position in TNGX as recently as Q4 2025.

David Shaw first reported a position in TNGX in Q2 2022 and has held it in 9 quarters since. The position peaked at $9.09M in Q4 2025. 256 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.

  • David Shaw held 60,382 shares of Tango Therapeutics worth $1.51M as of Q3 2026.
  • Tango Therapeutics was a new David Shaw position in Q3 2026.
  • Tango Therapeutics made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #3460 holding.
  • David Shaw first reported a position in Tango Therapeutics in Q2 2022 and has held it in 9 quarters since.
  • David Shaw's Tango Therapeutics position peaked at $9.09M in Q4 2025.
  • 256 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.